Skip to content

FDA Approved

Link to Linkedin
Link to Twitter

The State of Lung Imaging
About Xenon MRI
About Polarean
Xenon MRI Platform
- Inquiries
Clinical Research
Investors

FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized)

Posted on December 28, 2022January 26, 2023 by Brady Anna

Post navigation

Update on New Drug Application

FDA Grants New Chemical Entity designation for XENOVIEW™ (xenon Xe 129 hyperpolarized)

Terms & Conditions / Cookies Policy

Polarean, Inc. All rights reserved.

The State of Lung Imaging
About Xenon MRI
About Polarean
Xenon MRI Platform
- Inquiries
Clinical Research
Investors